What is an allergic reaction?

Discover the signs and symptoms of allergic reactions.

Hello, I am nurse Molly. Every day, I work with patients receiving asparaginase therapy for ALL or LBL.

Some patients may experience an allergic reaction to that therapy. The healthcare team may also refer to it as a hypersensitivity reaction.

Both acute lymphoblastic leukemia, or ALL, and lymphoblastic lymphoma, or LBL, are rare cancers of the blood and bone marrow that are most common in children, adolescents, and young adults.

Asparaginase is part of a multiagent therapy for ALL and LBL. Patients with ALL and LBL receive asparaginase therapy derived from E. coli bacteria. Even though it can help fight cancer, it can have unpleasant side effects.

Now let’s talk about:

One, what are allergic reactions to asparaginase therapy?

Two, what are the symptoms of an allergic reaction?

Three, what effect will an allergic reaction have on your cancer treatment?

Four, how are allergic reactions treated?

Five, who should you talk to if you experience an allergic reaction?

Number 1: what are allergic reactions to asparaginase therapy?

During treatment for ALL or LBL, you may experience an allergic reaction to your asparaginase therapy. An allergic reaction is when your body responds to something it doesn't like.

Just like your body may react to dust and pollen, certain foods such as peanuts, or even bee stings, it can also react to medicines meant to treat illness. Asparaginase, which can be derived from E. coli bacteria, can be one of those medicines.

Everyone is unique. Some people have a mild reaction, and some have a worse reaction. As many as 3 out of 10 patients may experience an allergic reaction after E. coli-derived asparaginase therapy.

Number 2: what are the symptoms of an allergic reaction?

Allergic reactions can make people feel sick. Some common symptoms that people with allergic reactions experience are itching, swelling of the mouth or skin, hives, headache, watery eyes, trouble breathing, vomiting, stomach cramps, or drop in blood pressure.

Most reactions to asparaginase happen quickly, but some reactions can occur up to 6 hours later.

Number 3: what effect will an allergic reaction have on your cancer treatment?

Experiencing an allergic reaction can mean that your current asparaginase therapy is not working as it should. Being treated again with the same type of asparaginase therapy that triggered an allergic reaction the first time can cause a similar or even worse response.

Number 4: how are allergic reactions treated?

Seek medical advice immediately if symptoms of an allergic reaction occur.

If you experience an allergic reaction to E. coli-derived asparaginase, your doctor and care team will decide whether to switch to a different type of asparaginase therapy—one that isn’t derived from E. coli. They will determine if switching to a different type can help ensure that your asparaginase therapy works correctly. This change also allows most patients to finish asparaginase therapy as the doctor intended.

A different type of asparaginase therapy derived from Erwinia chrysanthemi can have the same effect on your cancer as asparaginase derived from E. coli. Like E. coli-derived asparaginase, Erwinia-derived asparaginase may cause allergic reactions. Alert the healthcare team immediately if symptoms of an allergic reaction occur.

This different type of asparaginase therapy is short-acting, which means it is given more frequently to help ensure patients can maintain effective levels of asparaginase in their blood.

Number 5: who should you talk to if you experience an allergic reaction?

If you experience symptoms of an allergic reaction, alert your care team immediately and talk about a different type of asparaginase therapy. They can address your questions or concerns and support you in making the best decision for you.

What is RYLAZE?

RYLAZE is a prescription medicine, given by intramuscular injection, that is part of a chemotherapy regimen used to treat adults and children 1 month or older who have acute lymphoblastic leukemia (ALL), a type of blood cancer that affects the white blood cells that help fight infection, and lymphoblastic lymphoma (LBL), a type of non-Hodgkin lymphoma that also affects white blood cells. RYLAZE is used in patients who have had an allergic reaction to E. coli asparaginase.

IMPORTANT SAFETY INFORMATION

RYLAZE should not be given to people who have:

  • History of serious allergic reactions to RYLAZE
  • History of serious swelling of the pancreas (stomach pain), serious blood clots, or serious bleeding during previous asparaginase treatment
  • Severe damage to the liver

RYLAZE may cause serious side effects, including:

  • Allergic reactions (a feeling of tightness in your throat, unusual swelling/redness in your throat and/or tongue, rash, or trouble breathing), some of which may be life-threatening
  • Swelling of the pancreas (stomach pain), which, if left untreated, may be fatal
  • Blood clots (may be experienced as headache, arm or leg swelling, shortness of breath, or chest pain), which may be life-threatening
  • Bleeding, which may be life-threatening
  • Liver problems (may result in abnormal laboratory values) or, in severe cases, hepatic veno-occlusive disease (reduced blood flow in the liver)

Contact your doctor immediately if any of these side effects occur.

Some of the most common side effects with RYLAZE include:

  • Liver problems
  • Nausea and vomiting
  • Bone and muscle pain
  • Infection
  • Tiredness
  • Headache
  • Fever with low white blood cell count
  • Fever
  • Bleeding
  • Mouth swelling (sometimes with sores)
  • Pain in the abdomen
  • Decreased appetite
  • Allergic reactions
  • High blood sugar levels
  • Diarrhea
  • Swelling of the pancreas
  • Low levels of potassium in your blood

RYLAZE can harm your unborn baby. Inform your doctor if you are pregnant, planning to become pregnant, or nursing. Females of reproductive potential should use effective contraception (other than hormonal contraceptives) during treatment and for 3 months following the final dose. Do not breastfeed while receiving RYLAZE and for 1 week after the final dose.

Tell your healthcare provider if there are any side effects that are bothersome or that do not go away.

These are not all the possible side effects of RYLAZE. For more information, ask your healthcare provider.

Call your doctor for medical advice about any side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088 (1-800-332-1088).

Please see full Prescribing Information and discuss with your doctor.

What is RYLAZE?

RYLAZE is a prescription medicine, given by intramuscular injection, that is part of a chemotherapy regimen used to treat adults and children 1 month or older who have acute lymphoblastic leukemia (ALL), a type of blood cancer that affects the white blood cells that help fight infection, and lymphoblastic lymphoma (LBL), a type of non-Hodgkin lymphoma that also affects white blood cells. RYLAZE is used in patients who have had an allergic reaction to E. coli asparaginase.

IMPORTANT SAFETY INFORMATION & APPROVED USE

RYLAZE should not be given to people who have:

  • History of serious allergic reactions to RYLAZE
  • History of serious swelling of the pancreas (stomach pain), serious blood clots, or serious bleeding during previous asparaginase treatment
  • Severe damage to the liver

RYLAZE may cause serious side effects, including:

  • Allergic reactions (a feeling of tightness in your throat, unusual swelling/redness in your throat and/or tongue, rash, or trouble breathing), some of which may be life-threatening
  • Swelling of the pancreas (stomach pain), which, if left untreated, may be fatal
  • Blood clots (may be experienced as headache, arm or leg swelling, shortness of breath, or chest pain), which may be life-threatening
  • Bleeding, which may be life-threatening
  • Liver problems (may result in abnormal laboratory values) or, in severe cases, hepatic veno-occlusive disease (reduced blood flow in the liver)